Seroreactivity against aqueous-soluble and detergent-soluble retinal proteins in posterior uveitis

Archives of Ophthalmology

Volumn 129, Issue 4, 2011, Pages 415-420

  Ko, Audrey C ^a,d   Brinton, Jason P ^a   Mahajan, Vinit B ^a   Zimmerman, Bridget ^b   Brinton, Gregory S ^c   Stone, Edwin M ^a,e   Folk, James C ^a   Mullins, Robert F ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c Retina Associates of Utah   (United States)

^d Doris Duke Research Foundation   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOLASE C; ALPHA ENOLASE; AQUEOUS SOLUBLE RETINAL PROTEIN; CARBONATE DEHYDRATASE II; DETERGENT SOLUBLE RETINAL PROTEIN; FRUCTOSE BISPHOSPHATE ALDOLASE ISOENZYME; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NEURON SPECIFIC ENOLASE; PROTEIN; PROTEIN TULP 1; RECOVERIN; S ARRESTIN; TRANSDUCIN; UNCLASSIFIED DRUG;

ACUTE ZONAL OCCULT OUTER RETINOPATHY; ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; EYE FUNDUS; FEMALE; GEL ELECTROPHORESIS; HUMAN; LEBER CONGENITAL AMAUROSIS; MALE; MOLECULAR WEIGHT; OCULAR HISTOPLASMOSIS; PHOTORECEPTOR; PHOTORECEPTOR DEGENERATION; PRIORITY JOURNAL; RETINA DEGENERATION; RETINITIS PIGMENTOSA; RETINOPATHY; STATISTICAL SIGNIFICANCE; UVEITIS; WESTERN BLOTTING;

ADOLESCENT; ADULT; AUTOANTIBODIES; AUTOANTIGENS; BLOTTING, WESTERN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EYE PROTEINS; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; RETINA; RETINAL DEGENERATION; SOLUBILITY; UVEITIS, POSTERIOR; YOUNG ADULT;

EID: 79953907827     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.65     Document Type: Article

References (21)

1. Xu H, Forrester JV, Liversidge J, Crane IJ. Leukocyte trafficking in experimental autoimmune uveitis: breakdown of blood-retinal barrier and upregulation of cellular adhesion molecules. Invest Ophthalmol Vis Sci. 2003;44(1):226-234. (Pubitemid 36134279)
2. Kerr EC, Copland DA, Dick AD, Nicholson LB. The dynamics of leukocyte infiltration in experimental autoimmune uveoretinitis. Prog Retin Eye Res. 2008; 27(5):527-535.
3. Kerr EC, Raveney BJ, Copland DA, Dick AD, Nicholson LB. Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations. J Autoimmun. 2008;31(4):354-361.
4. Heckenlively JR, Ferreyra HA. Autoimmune retinopathy: a review and summary. Semin Immunopathol. 2008;30(2):127-134.
5. Whittle RM, Wallace GR, Whiston RA, Dumonde DC, Stanford MR. Human antiretinal antibodies in toxoplasma retinochoroiditis. Br J Ophthalmol. 1998; 82(9):1017-1021. (Pubitemid 28451272)
6. de Smet MD, Yamamoto JH, Mochizuki M, et al. Cellular immune responses of patients with uveitis to retinal antigens and their fragments. Am J Ophthalmol. 1990;110(2):135-142. (Pubitemid 20242334)
7. Weleber RG, Watzke RC, Shults WT, et al. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies. Am J Ophthalmol. 2005;139(5):780-794. (Pubitemid 40614762)
8. Adamus G, Ren G, Weleber RG. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol. June 4, 2004;4:5.
9. Lu Y, Jia L, He S, et al. Melanoma-associated retinopathy: a paraneoplastic autoimmune complication. Arch Ophthalmol. 2009;127(12):1572-1580.
10. Ferreyra HA, Jayasundera T, Khan NW, He S, Lu Y, Heckenlively JR. Management of autoimmune retinopathies with immunosuppression. Arch Ophthalmol. 2009;127(4):390-397.
11. Heckenlively JR, Fawzi AA, Oversier J, Jordan BL, Aptsiauri N. Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration. Arch Ophthalmol. 2000;118(11):1525-1533.
12. Galbraith GM, Emerson D, Fudenberg HH, Gibbs CJ, Gajdusek DC. Antibodies to neurofilament protein in retinitis pigmentosa. J Clin Invest. 1986;78(4):865-869. (Pubitemid 17177062)
13. Ko AC, Hernández J, Brinton JP, et al. Anti-γ-enolase autoimmune retinopathy manifesting in early childhood. Arch Ophthalmol. 2010;128(12):1590-1595.
14. Shimazaki K, Jirawuthiworavong GV, Heckenlively JR, Gordon LK. Frequency of anti-retinal antibodies in normal human serum. J Neuroophthalmol. 2008;28 (1):5-11. (Pubitemid 351416884)
15. Heckenlively JR, Jordan BL, Aptsiauri N. Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol. 1999;127(5):565-573. (Pubitemid 29215768)
16. Jap A, Chee SP. Immunosuppressive therapy for ocular diseases. Curr Opin Ophthalmol. 2008;19(6):535-540.
17. Jampol LM, Fishman GA. Immunosuppression for autoimmune retinopathy. Arch Ophthalmol. 2009;127(4):573-575.
18. Heckenlively JR, Ferreyra HA, Janasundera T. Controversies of diagnosing autoimmune retinopathy. Arch Ophthalmol. 2010;128(1):147-148.
19. Fishman GA, Jampol LM. Controversies of diagnosing autoimmune retinopathy [in reply]. Arch Ophthalmol. 2009;128(1):148-149.
20. Gregerson DS, Abrahams IW, Thirkill CE. Serum antibody levels of uveitis patients to bovine retinal antigens. Invest Ophthalmol Vis Sci. 1981;21(5):669-680. (Pubitemid 12229213)
21. Whitcup SM, Vistica BP, Milam AH, Nussenblatt RB, Gery I. Recoverinassociated retinopathy: a clinically and immunologically distinctive disease. Am J Ophthalmol. 1998;126(2):230-237. (Pubitemid 28397096)